{
    "eid": "2-s2.0-85129697282",
    "title": "Therapeutic drug monitoring of meropenem and pharmacokinetic-pharmacodynamic target assessment in critically ill pediatric patients from a prospective observational study",
    "cover-date": "2022-07-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Microbiology (medical)",
            "@code": "2726",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Critically ill patients",
        "Extended infusion",
        "Meropenem",
        "Pediatric",
        "Therapeutic drug monitoring"
    ],
    "authors": [
        "Passara Maimongkol",
        "Wanlika Yonwises",
        "Suvaporn Anugulruengkitt",
        "Jiratchaya Sophonphan",
        "Wanchai Treyaprasert",
        "Noppadol Wacharachaisurapol"
    ],
    "citedby-count": 2,
    "ref-count": 42,
    "ref-list": [
        "Antimicrobial therapeutic drug monitoring in critically ill adult patients: a position paper",
        "Augmented renal clearance using population-based pharmacokinetic modeling in critically ill pediatric patients",
        "Treatment of infections due to MDR Gram-negative bacteria",
        "The effect of pathophysiology on pharmacokinetics in the critically ill patient\u2014concepts appraised by the example of antimicrobial agents",
        "A method for determining the free (unbound) concentration of ten beta-lactam antibiotics in human plasma using high performance liquid chromatography with ultraviolet detection",
        "Comparison of piperacillin plasma concentrations in a prospective randomised trial of extended infusion versus intermittent bolus of piperacillin/tazobactam in paediatric patients",
        "Population pharmacokinetics and pharmacodynamic target attainment of meropenem in critically ill young children",
        "Performance standards for antimicrobial susceptibility testing",
        "Pharmacokinetics and pharmacodynamics of continuous-infusion meropenem in pediatric hematopoietic stem cell transplant patients",
        "Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial",
        "Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases",
        "Augmented renal clearance in pediatric intensive care: are we undertreating our sickest patients?",
        "Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial",
        "Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of \u03b2-lactams",
        "Treatment of multidrug-resistant Gram-negative infections in children",
        "Pharmacodynamics of meropenem in critically ill patients with febrile neutropenia and bacteraemia",
        "Pharmacokinetics and pharmacodynamics of meropenem in children with severe infection",
        "Early antimicrobial therapy in severe sepsis and septic shock",
        "Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections",
        "Diagnostic and medical needs for therapeutic drug monitoring of antibiotics",
        "Therapeutic drug monitoring of beta-lactams and other antibiotics in the intensive care unit: which agents, which patients and which infections?",
        "Pharmacokinetic and pharmacodynamic properties of meropenem",
        "Optimal dosage regimen of meropenem for pediatric patients based on pharmacokinetic/pharmacodynamic considerations",
        "Scoping review of augmented renal clearance in critically ill pediatric patients",
        "Continuous versus intermittent \u03b2-lactam infusion in severe sepsis. A meta-analysis of individual patient data from randomized trials",
        "Pharmacokinetic issues for antibiotics in the critically ill patient",
        "DALI: defining antibiotic levels in intensive care unit patients: are current beta-lactam antibiotic doses sufficient for critically ill patients?",
        "Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept",
        "Usefulness of therapeutic drug monitoring of piperacillin and meropenem in routine clinical practice: a prospective cohort study in critically ill patients",
        "New equations to estimate GFR in children with CKD",
        "Abdel-Hady H. Conventional versus prolonged infusion of meropenem in neonates with Gram-negative late-onset sepsis: a randomized controlled trial",
        "Can therapeutic drug monitoring optimize exposure to piperacillin in febrile neutropenic patients with haematological malignancies? A randomized controlled trial",
        "ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients",
        "Pharmacodynamics of cefepime in patients with Gram-negative infections",
        "Clinical implications of antibiotic pharmacokinetic principles in the critically ill",
        "Meropenem population pharmacokinetics in critically ill patients with septic shock and continuous renal replacement therapy: influence of residual diuresis on dose requirements",
        "Prolonged versus short-term intravenous infusion of antipseudomonal \u03b2-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials",
        "Population pharmacokinetics of meropenem in critically ill infant patients",
        "Clinical outcomes of prolonged infusion (extended infusion or continuous infusion) versus intermittent bolus of meropenem in severe infection: A meta-analysis",
        "Comparative review of the carbapenems",
        "Extended or continuous infusion of carbapenems in children with severe infections: a systematic review and narrative synthesis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60016965",
            "affilname": "The HIV Netherlands Australia Thailand Research Collaboration",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016965",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "King Chulalongkorn Memorial Hospital",
        "Chulalongkorn University"
    ]
}